Product Information

FOCALIN XR 10 MG CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $4.7606 per EA under NDC 00078043105. Its NADAC has been published 657 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the dexmethylphenidate hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FOCALIN XR 10 MG CAPSULE

dexmethylphenidate hydrochloride
$4.7606per EA
High Outlier
DEA Schedule CII

Strength

10 mg/1

NDC

00078043105

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021802

On Market Since

5/31/2005

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for FOCALIN XR 10 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 27.7%. The table below summarizes its recorded NADAC range and movement.

Current price$4.7606 per EA
All-time high$13.1955 (Mar 27, 2024)
All-time low$4.7590 (May 20, 2026)
52-week high$4.7860
52-week low$4.7590
Median price$11.1102
Average price$9.9223
Largest weekly change-63.8% (Apr 3, 2024)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.0%

3M

-0.2%

6M

-0.2%

1Y

-0.5%

3Y

-63.9%

5Y

-61.4%

All

-27.7%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FOCALIN XR 10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for FOCALIN XR 10 MG CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $4.7606 per EA (NDC 00078043105), effective Jun 24, 2026.

How has the price of FOCALIN XR 10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for FOCALIN XR 10 MG CAPSULE has declined 27.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for FOCALIN XR 10 MG CAPSULE?

Since Nov 28, 2013, the NADAC for FOCALIN XR 10 MG CAPSULE has ranged from a low of $4.7590 (May 20, 2026) to a high of $13.1955 (Mar 27, 2024), with a median of $11.1102 per EA.

Are there cheaper alternatives to FOCALIN XR 10 MG CAPSULE?

Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DEXMETHYLPHENIDATE 10 MG TAB, is $0.3391 per EA — about 93% below FOCALIN XR 10 MG CAPSULE.

Who manufactures FOCALIN XR 10 MG CAPSULE?

FOCALIN XR 10 MG CAPSULE (NDC 00078043105) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.